These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 7014886)
1. Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication. Bancewicz J; Calman KC; Macpherson SG; McArdle CS; McVie JG; Soukop M J R Soc Med; 1980 Mar; 73(3):197-9. PubMed ID: 7014886 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for patients with resected Dukes' C and high-risk B2 colon cancer with fluorouracil and levamisole. Au E; Ang PT; Seow-Choen F; Soo KC; Low CH; Chng HC; Ng BK Ann Acad Med Singap; 1998 Sep; 27(5):733-7. PubMed ID: 9919352 [TBL] [Abstract][Full Text] [Related]
3. A systematic overview of chemotherapy effects in colorectal cancer. Ragnhammar P; Hafström L; Nygren P; Glimelius B; Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937 [TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure. Wunderlich M; Schiessel R; Rainer H; Rauhs R; Kovats E; Schemper M; Dittrich C; Micksche M; Sedlacek HH Br J Surg; 1985 Sep; 72 Suppl():S107-10. PubMed ID: 3899250 [TBL] [Abstract][Full Text] [Related]
5. Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Windle R; Bell PR; Shaw D Br J Surg; 1987 Jul; 74(7):569-72. PubMed ID: 3304518 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy in colorectal cancer. (A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the methanol extraction residue of BCG, MER). Robinson E; Bartal A; Cohen Y; Milstein D; Mekori T Biomedicine; 1979 Feb; 31(1):8-10. PubMed ID: 383171 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant immunochemotherapy in colorectal cancer Dukes C. Sertoli MR; Guarneri D; Rubagotti A; Porcile G; Nobile MT; Rosso R Oncology; 1987; 44(2):78-81. PubMed ID: 3554085 [TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil-interferon-alpha 2b adjuvant treatment of Dukes C colorectal cancer. Frasci G; Leone F; Monaco M; Cremone L; Sapio U; Faiella F; Espinosa A; Persico G Dis Colon Rectum; 1994 Jul; 37(7):643-50. PubMed ID: 8026229 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival. Mavligit GM; Gutterman JU; Malahy MA; Burgess MA; McBride CM; Jubert A; Hersh EM Cancer; 1977 Nov; 40(5 Suppl):2726-30. PubMed ID: 922710 [TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group. Lancet; 2000 May; 355(9215):1588-96. PubMed ID: 10821362 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time. Hafström L; Rudenstam CM; Domellöf L Br J Surg; 1985 Feb; 72(2):138-41. PubMed ID: 3882183 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy of colorectal cancer. Kemeny N; Saltz L; Cohen A Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089 [TBL] [Abstract][Full Text] [Related]
14. Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG). Robinson E; Bartal A; Cohen Y; Haim N; Mohilever J; Mekori T Cancer Chemother Pharmacol; 1982; 8(1):35-40. PubMed ID: 7094200 [TBL] [Abstract][Full Text] [Related]
15. [Adjuvant treatment of resected colon cancers using a 5-fluorouracil-levamisole combination]. Ducreux M Gastroenterol Clin Biol; 1991; 15(8-9):665-7. PubMed ID: 1752386 [No Abstract] [Full Text] [Related]
16. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen CM; Ungerleider JS; Emerson WA; Tormey DC; Glick JH; Veeder MH; Mailliard JA Ann Intern Med; 1995 Mar; 122(5):321-6. PubMed ID: 7847642 [TBL] [Abstract][Full Text] [Related]
17. Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil. Mavligit GM; Gutterman JU; Burgess MA; Khankhanian N; Seibert GB; Speer JF; Jubert AV; Martin RC; McBride CM; Copeland EM; Gehan EA; Hersh EM Lancet; 1976 Apr; 1(7965):871-6. PubMed ID: 58143 [TBL] [Abstract][Full Text] [Related]
18. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group. Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947 [TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy of metastatic large bowel cancer: nonspecific stimulation with BCG and levamisole. Valdivieso M; Bedikian A; Burgess MA; Rodriguez V; Hersh EM; Bodey GP; Mavligit GM Cancer; 1977 Nov; 40(5 Suppl):2731-9. PubMed ID: 336190 [TBL] [Abstract][Full Text] [Related]
20. [Adjuvant chemotherapy in cancers of the colon and rectum]. Bleiberg H Rev Prat; 1994 Dec; 44(20):2721-6. PubMed ID: 7878362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]